Improvements in cardiometabolic markers, such as blood pressure, cholesterol levels, and fasting blood sugar levels, are also likely to reverse when discontinuing a GLP-1
Although the price of the medicine can seem steep, many doctors emphasize that it can save money and health problems in the long run by reducing risks linked to conditions like heart disease or unmanaged diabetes
According to UK SmPCs, nausea, vomiting, diarrhoea and constipation can affect between 10-40% of patients, with higher rates typically seen at weight management doses
Abstract Glucagon-like peptide (GLP)-1 receptor agonists are the cornerstone in the treatment of hyperglycemia in many people suffering from type 2 diabetes (T2D)
Mishra B, Kumbhare LB, Jain VK, Priyadarsini KI (2008) Pulse radiolysis studies on reactions of hydroxyl radicals with selenocystine derivatives
In patients with CKD who are at increased risk for cardiovascular events, use of a GLP-1 RA may reduce the risk of progression of albuminuria, cardiovascular events, or both